SERPINE1 and neoplasm: PAI-1 inhibits urokinase-type plasminogen activator (uPA) and tissue type plasminogen activator (tPA), leading to attenuation of plasminogen activation, which is associated with inflammatory migration and angiogenesis at tumor sites [42].